Compare Devon Energy Corp (DVN) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Devon Energy Corp trades at $50.03 (market cap $55.23B), while GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B). The key difference: Devon Energy Corp is the larger of the two by market cap, and Devon Energy Corp pays the higher dividend (2.55%). Which is the better fit depends on your goals.
| DVN | GEHC | |
|---|---|---|
Market Cap | $55.23B | $31.07B |
Volume | 10,032,111 | 3,443,020 |
Sector | Energy | Health |
52-Week High | $52.07 | $88.16 |
52-Week Low | $31.74 | $59.48 |
Typical Hold Time | 136 Days | — |
Enterprise Value | $65.97B | $39.53B |
Dividend Yield | 2.55% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $49.92, up 1.96% with strong bullish technical signals from moving averages. The stock shows attractive valuation metrics including a P/E of 10.92 and P/S of 1.79, while maintaining solid profitability with 16.67% net margins. Recent activist investor pressure for strategic alternatives and potential asset sales create catalysts, though the company faces earnings volatility with mixed quarterly results including a Q1 miss but Q2 beat.
DVN presents value opportunity with 25% upside to consensus target of $62.53, supported by 72% analyst buy ratings. Key risks include oil price sensitivity and execution on asset sales, while the improving cash flow trend and Permian Basin focus provide fundamental support. The combination of reasonable valuation and strategic optionality makes DVN compelling for energy investors.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
